Erratum: Early identification and management of chronic kidney disease: Summary of NICE guidance (BMJ (Online) (2008) 337 (a1530) DOI: 10.1136/bmj.a1530);Early identification and management of chronic kidney disease: Summary of NICE guidance

BMJ

Volumn 337, Issue 7673, 2008, Pages 812-815

  Crowe, Emily ^a   Halpin, David ^b   Stevens, Paul ^c  

^a ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

^b ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^c KENT AND CANTERBURY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANEMIA; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; GLOMERULUS FILTRATION RATE; HEALTH CARE ORGANIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; PRIORITY JOURNAL; REVIEW; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLASSIFICATION; EARLY DIAGNOSIS; KIDNEY DISEASE; PRACTICE GUIDELINE; RISK FACTOR;

ANEMIA; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; EARLY DIAGNOSIS; HUMANS; KIDNEY DISEASES; RISK FACTORS;

EID: 53649110564     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g5045     Document Type: Erratum

References (22)

1. Drey N, Roderick P, Mullee M, Rogerson M. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 2003;42:677-84.
2. John R, Webb M, Young A, Stevens PE. Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis 2004;43:825-35.
3. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004;164:659-63.
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305.
5. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(suppl 1):S1-266.
6. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third national health and nutrition examination survey. Am J Kidney Dis 2003;41:1-12.
7. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-47
8. Glassock RJ, Winearls C. An epidemic of chronic kidney disease: fact or fiction? Nephrology Dialysis and Transplantation 2008;23:1117-21.
9. Stevens PE, O'Donoghue DJ, de Lusignan S, van Vlymen J, Klebe B, Middleton R, et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 2007;72:92-9.
10. Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003;63:1468-74.
11. Klausen K, Borch JK, Feldt RB, Jensen G, Clausen P, Scharling H, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004;110:32-5.
12. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de ZD, van Veldhuisen DJ, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002;106:1777-82.
13. Arnlov J, Evans JC, Meigs J B, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham heart study. Circulation 2005;112:969-75.
14. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F. Expressing the MDRD study equation for estimating GFR with standardised serum creatinine values. Clin Chem 2007;53:766-72
15. National Institute for Health and Clinical Excellence. Hypertension: management of hypertension in adults in primary care. 2006. (Clinical guideline 34.) www.nice.org.uk/guidance/index.jsp? action=byID&o=10986
16. National Institute for Health and Clinical Excellence. Type 2 diabetes: the management of type 2 diabetes (update). 2008. (Clinical guideline 66.) www.nice.org.uk/CG66.
17. National Institute for Health and Clinical Excellence. Anaemia management in people with chronic kidney disease (CKD). 2006. (Clinical guideline 39.) www.nice.org.uk/CG39.
18. Foster MC, Hwang SJ, Larson MG, Parikh NI, Meigs JB, Vasan RS, et al. Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes. Arch Intern Med 2007;167:1386-92.
19. Hallan S, Astor B, Romundstad S, Aasarod K, Kvenild K, Coresh J. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: the HUNT II study. Arch Intern Med 2007;167:2490-6.
20. Cirillo M, Lanti MP, Menotti A, Laurenzi M, Mancini M, Zanchetti A, et al. Definition of kidney dysfunction as a cardiovascular risk factor: use of urinary albumin excretion and estimated glomerular filtration rate. Arch Intern Med 2008;168:617-24.
21. Brantsma AH, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT. Extended prognostic value of urinary albumin excretion for cardiovascular events. J Am Soc Nephrol 2008;19:1785-91.
22. Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT, et al. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion. Nephrol Dial Transplant 2008; advance access 18 Jul, doi:10.1093/ndt/gfn356